TPG Plans to Acquire Envision Pharmaceutical Parent
Private equity firm TPG announced on Monday that it planned to acquire the parent company of Envision Pharmaceutical Services. The acquisition would be subject to conditions and pending issuance of regulatory clearances. However, all other financial details of the acquisition were not disclosed. Officials were expecting the deal to close by fourth quarter this year.
TPG was a leading private equity investment firm in the world, with around US$56.7 billion of assets globally. The company has its headquarters in Fort Worth, Texas and San Francisco, California, with offices in North America, Australia, Asia, and Europe.
The firm was focused on growth capital, leveraged buyouts, and leveraged recapitalization investments. It also managed investments funds and specialized in debt investments, public equity, growth capital, venture capital, and public equity.
The investments of the private equity firm covered various industries. These include health care, travel and leisure, consumer/retail, industrials, media and telecommunications, and technology.
Join the Conversation